We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.52%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.91B
AUM Growth
+$381M
Cap. Flow
+$284M
Cap. Flow %
14.88%
Top 10 Hldgs %
12.83%
Holding
585
New
93
Increased
156
Reduced
181
Closed
119

Top Sells

Rank Stock Value
1
EXEL icon
Exelixis
EXEL
+$10.6M
2
YELP icon
Yelp
YELP
+$7.74M
3
AAPL icon
Apple
AAPL
+$7.65M
4
MMM icon
3M
MMM
+$7.04M
5
FTI icon
TechnipFMC
FTI
+$7.03M

Sector Composition

Rank Sector Weight
1 Technology 19.89%
2 Healthcare 13.64%
3 Consumer Discretionary 13.32%
4 Financials 13.11%
5 Industrials 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVRI icon
301
Enviri
NVRI
$621M
$1.15M 0.06%
90,500
-24,300
-21% -$325K
CLDX icon
302
Celldex Therapeutics
CLDX
$2.77B
$1.15M 0.06%
21,247
-3,373
-14% -$176K
FRAN
303
DELISTED
Francesca's Holdings Corporation
FRAN
$1.14M 0.06%
6,187
-6,315
-51% -$1.31M
NSTG
304
DELISTED
NanoString Technologies, Inc.
NSTG
$1.13M 0.06%
+57,000
New +$1.08M
CRMT icon
305
America's Car Mart
CRMT
$25.3M
$1.13M 0.06%
+31,000
New +$1.19M
ONTO icon
306
Onto Innovation
ONTO
$13.6B
$1.11M 0.06%
36,400
+10,036
+38% +$272K
FCF icon
307
First Commonwealth Financial
FCF
$2.12B
$1.1M 0.06%
83,069
+38,569
+87% +$533K
HMHC
308
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$1.1M 0.06%
108,400
-16,900
-13% -$177K
FIVN icon
309
FIVE9
FIVN
$1.77B
$1.1M 0.06%
66,585
-21,300
-24% -$350K
PCMI
310
DELISTED
PCM, Inc
PCMI
$1.09M 0.06%
38,959
+23,422
+151% +$598K
FOXF icon
311
Fox Factory Holding Corp
FOXF
$776M
$1.09M 0.06%
37,868
-3,182
-8% -$86.5K
BCRX icon
312
BioCryst Pharmaceuticals
BCRX
$2.37B
$1.08M 0.06%
129,200
-1,594
-1% -$11.1K
WSFS icon
313
WSFS Financial
WSFS
$4.1B
$1.08M 0.06%
23,474
+4,900
+26% +$223K
FELE icon
314
Franklin Electric
FELE
$4.67B
$1.08M 0.06%
25,000
-3,800
-13% -$155K
PDFS icon
315
PDF Solutions
PDFS
$2.13B
$1.07M 0.06%
+47,400
New +$1.06M
LUMO
316
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.07M 0.06%
4,944
-689
-12% -$98.4K
HBM icon
317
Hudbay
HBM
$9.92B
$1.06M 0.06%
+161,912
New +$1.21M
AMRI
318
DELISTED
Albany Molecular Research Inc
AMRI
$1.05M 0.06%
75,020
+43,420
+137% +$711K
CTRL
319
DELISTED
Control4 Corporation
CTRL
$1.04M 0.05%
66,200
+35,800
+118% +$480K
RYAM icon
320
Rayonier Advanced Materials
RYAM
$565M
$1.04M 0.05%
77,000
-12,300
-14% -$173K
LXP icon
321
LXP Industrial Trust
LXP
$3.53B
$1.01M 0.05%
+20,300
New +$1.08M
VCRA
322
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$1M 0.05%
40,350
+13,750
+52% +$291K
USNA icon
323
Usana Health Sciences
USNA
$394M
$996K 0.05%
17,300
-13,408
-44% -$800K
KEYW
324
DELISTED
The KEYW Holding Corporation
KEYW
$986K 0.05%
104,500
+59,600
+133% +$615K
STRA icon
325
Strategic Education
STRA
$1.71B
$974K 0.05%
12,102
-1,498
-11% -$120K

Similar funds

PDT Partners's Q1 2017 Portfolio in Review

As of Q1 2017, PDT Partners held 585 positions worth $1.91B, up 25% from $1.53B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

PDT Partners deployed $284M of net new capital in Q1 2017, opening 93 new positions and adding to 156 existing holdings. Its largest new stake was American Express: 265,800 shares worth $21M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Yelp, an estimated $7.74M trimmed.

  • PDT Partners's largest Q1 2017 buy was American Express: 265,800 shares worth $21M.
  • PDT Partners added most to Transocean in Q1 2017, an estimated $14.2M increase.
  • PDT Partners's biggest Q1 2017 reduction was Yelp, cutting an estimated $7.74M.
  • PDT Partners fully exited Exelixis in Q1 2017, selling an estimated $10.6M.
  • PDT Partners's ten largest holdings make up 13% of its $1.91B portfolio in Q1 2017.
  • PDT Partners opened 93 new positions and closed 119 in Q1 2017.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.91B.

Based on PDT Partners's 13F filing for Q1 2017, filed 15 May 2017.